Pyrogen Testing Market Size, Share, Growth Report 2030

Global Pyrogen Testing Market: Industry Perspective

The global Pyrogen Testing Market accounted for USD 785.2 Million in 2020 and is expected to reach USD 2,008.4 Million by 2028, growing at a CAGR of 12.4% from 2021 to 2028.      

Pyrogen testing is a critical step in ensuring the safety of parenteral pharmaceutical products and medical devices. It is part of the mandatory release tests to avoid life-threatening fever reactions induced by pyrogenic substances.  

The players are focusing aggressively on innovation, as well as on including advanced technologies in their existing products. Over the coming years, they are also expected to take up partnerships and mergers and acquisitions as their key strategy for business development. Citing an instance, in May 2018, MilliporeSigma and Solvias decided to enter into collaboration for providing PyroMat System, an innovative monocyte activation test kit developed by both firms for Pyrogen detection, to customers.

Request Free Sample

COVID-19 Impact Analysis:

The pandemic has led to increasing demand for drugs and APIs, those used against malaria are most in the demand, and then antibiotics and antivirals. The second wave of deficiency is observed among various diseases patients which are needed to care. As the pandemic progresses, the manufacturer of Pyrogen Testing works around the clock to ensure American patients have access to the drugs they need.

The covid-19 has created an opportunity for the number of patients as there is a high chance of adverse health effects of covid-19 on people. However, the covid-19 has positively impacted the Pyrogen Testing market.

Pyrogen Testing Market: Growth Factors  

The introduction of new drugs and the rise in the R&D activities witnessed across pharmaceutical and biotech sectors are anticipated to spur the Pyrogen testing market size over the coming years. Apart from this, massive funding for research & development activities pertaining to drug development along with favorable government policies stimulating the growth of Pharma & biotech industries will further boost the industry trends in the years ahead.

Lack of healthcare amenities and low availability of advanced Pyrogen testing devices, however, is anticipated to obstruct the Pyrogen testing market growth over the forthcoming years. Nevertheless, the increase in the number of outsourcing activities observed across the pharmaceutical sector is projected to generate a profitable roadmap for the Pyrogen testing industry over the ensuing years, normalizing the impact of hindrances on the Pyrogen testing market.

Report Scope:

Product Segment Analysis Preview

On the basis of Product, the global gas market is segmented into Instruments, Services, and Kits and Reagents. The kits and Reagents market segment held the largest market share due to huge demand across the globe.  

Test Segment Analysis Preview

On the basis of Tests, the Pyrogen Testing market is segmented into In Vitro, LAL tests, and rabbits. The LAL Test segment is estimated to account for the largest Pyrogen Testing market share among all the Tests. This is attributed to the rapid growth in the pharmaceutical and biotechnology industries, increasing demand for medical devices, increasing health standards, rising need for innovative laboratory testing procedures, and the growing drug pipelines.

Application Segment Analysis Preview

On the basis of Application, the Pyrogen Testing market is segmented into Pharmaceutical & Biotechnology, Medical Devices, and Others. The pharmaceutical & Biotechnology segment held the largest market share due to huge demand across the globe for the growth of the Pyrogen Testing market.

Request Free Sample

Pyrogen Testing Market: Regional Segment Analysis Preview

North America has been leading the worldwide Pyrogen testing market and is anticipated to continue in the dominant position in the years to come, states the Pyrogen testing market study. The presence of a well-established medical and healthcare infrastructure and skilled healthcare professionals has played a vital role in the dominance of the North America Pyrogen testing market. The high number of market players headquartered in North America is another significant factor that is supporting this regional Pyrogen testing market.

Pyrogen Testing Market: Key Players & Competitive Landscape

The major players operating in the Pyrogen Testing market are Thermo Fisher Scientific, Inc., Associates of Cape Cod, Inc., Charles River Laboratories, Inc., Ellab A/S, Genscript, Hyglos GmbH, Lonza Group, Merck Kgaa, WUXI Pharmatech (Cayman) Inc. and Wako Chemicals Usa, Inc.

Request Free Sample

The global Pyrogen Testing market is segmented as follows:   

By Product

• Instruments
• Services
• Kits and Reagents

By Test  

• In Vitro
• LAL Test
• Rabbit

By Application

• Pharmaceutical & Biotechnology
• Medical Devices
• Other

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of the Middle East & Africa